[Cholestasis and pancreatic insufficiency: how to start treatment?].
The article presents a detailed analysis of pathogenesis and clinical manifestation of secondary pancreatic excretory insufficiency due to disorders of bile production and choleresis. Pathogenesis of hepatogenic (chologenic) pancreatic insufficiency considered in view of impairment of bile acids' different functions in cholestasis. Authors review pathology of liver and bile ducts resulted in steatorrhea. It was conducted pathogenetic substantiation treatment tactics of patients, which have a combination of cholestasis and secondary pancreatic insufficiency.
N B
NB
Gubergrits
G M
GM
Lukashevich
D002779:Cholestasis / Q000150:complications / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D056947:Enzyme Replacement Therapy / Q000379:methods*; D010188:Exocrine Pancreatic Insufficiency / Q000188:drug therapy* / Q000201:enzymology / Q000209:etiology; D006801:Humans; D008049:Lipase / Q000008:administration & dosage / Q000627:therapeutic use; D008863:Microspheres; D010627:Phenethylamines / Q000008:administration & dosage / Q000627:therapeutic use*; D019936:Probiotics / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D010627:Phenethylamines; C005096:mebeverine; D008049:Lipase